Susan D. Berland - Jul 13, 2022 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role: Director
Signature: /s/ Mike Rhee, attorney-in-fact
Stock symbol: SNTI
Transactions as of: Jul 13, 2022
Transactions value $: $0
Form type: 4
Date filed: 7/15/2022, 06:00 PM
Previous filing: Jun 15, 2022
Next filing: Jun 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SNTI	Stock Option (Right to Buy)	Award	$0	+125K		$0.00	125K	Jul 13, 2022	Common Stock	125K	$1.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission.

Content

The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission.